CANTONI, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 14.178
AS - Asia 488
SA - Sud America 74
NA - Nord America 48
AF - Africa 19
Totale 14.807
Nazione #
IT - Italia 14.160
SG - Singapore 219
CN - Cina 120
VN - Vietnam 108
BR - Brasile 47
US - Stati Uniti d'America 34
AR - Argentina 16
HK - Hong Kong 12
MX - Messico 9
ID - Indonesia 8
ZA - Sudafrica 6
EC - Ecuador 4
NO - Norvegia 4
BD - Bangladesh 3
CL - Cile 3
IN - India 3
IQ - Iraq 3
MA - Marocco 3
AT - Austria 2
CO - Colombia 2
DZ - Algeria 2
GB - Regno Unito 2
JO - Giordania 2
KE - Kenya 2
PK - Pakistan 2
RU - Federazione Russa 2
UA - Ucraina 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CA - Canada 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ES - Italia 1
ET - Etiopia 1
GA - Gabon 1
IE - Irlanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
NL - Olanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
SE - Svezia 1
SV - El Salvador 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 14.807
Città #
Genova 9.136
Genoa 2.993
Rapallo 1.048
Vado Ligure 957
Singapore 98
Ho Chi Minh City 37
Beijing 31
Hanoi 29
Ashburn 21
Bordighera 20
Hong Kong 12
Tianjin 11
Haiphong 6
Mexico City 6
Ninh Bình 6
Johannesburg 4
San Jose 4
Biên Hòa 3
Nha Trang 3
Oslo 3
Quảng Ngãi 3
Salvador 3
Albuzzano 2
Amman 2
Atlanta 2
Bắc Ninh 2
Da Nang 2
Dhaka 2
Duque de Caxias 2
Guangzhou 2
Hangzhou 2
Milan 2
Montes Claros 2
Nairobi 2
Olivos 2
Porto Alegre 2
Ribeirão das Neves 2
Rio de Janeiro 2
Rondonópolis 2
São Gonçalo 2
São Paulo 2
Abidjan 1
Addis Ababa 1
Alvorada 1
Ambato 1
Amsterdam 1
Ankara 1
Armação dos Búzios 1
Baghdad 1
Baie-D'Urfé 1
Baku 1
Barretos 1
Betim 1
Bila Tserkva 1
Blumenau 1
Brasília 1
Brazzaville 1
Bridgetown 1
Bucaramanga 1
Buenos Aires 1
Bến Cầu 1
Cachoeiras de Macacu 1
Candelaria 1
Cape Town 1
Casilda 1
Chascomús 1
Chennai 1
Concepción 1
Curitiba 1
Córdoba 1
Delhi 1
Dolores 1
Dublin 1
El Bosque 1
Estância Velha 1
Fes 1
Formosa 1
Grand Rapids 1
Guarulhos 1
Guayaquil 1
Huế 1
Hải Dương 1
Ipatinga 1
Isidro Casanova 1
Itu 1
Ituzaingó 1
Jakarta 1
Joinville 1
José Bonifácio 1
Jurema 1
Kairouan 1
Karawang 1
Kirkuk 1
Lahore 1
Lavras 1
Lima 1
Lomas de Zamora 1
Luanda 1
Macaé 1
Makassar 1
Totale 14.531
Nome #
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 214
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 199
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 198
Role of the calpain-calpastatin system in the density-dependent growth arrest 186
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 182
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 181
A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. 178
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 177
Effect of tumor cells and tumor microenvironment on NK-cell function. 176
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 174
Involvement of exon 6-mediated calpastatin intracellular movements in the modulation of calpain activation. 170
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 170
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 169
Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a 167
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 166
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 165
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 164
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 163
Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones. 163
A novel type of GABA receptor in rat spinal cord? 163
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 162
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 162
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 158
Molecular structures of HLA-specific human NK cell receptors. 157
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 156
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 155
Characterization of human afferent lymph dendritic cells from seroma fluids. 155
DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis 152
Characterization of a cyclosporin A-sensitive activation pathway in cultured T and natural killer cells. 152
Crystal structure of the extracellular domain of the human natural killer cell activating receptor NKp44 150
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 149
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 148
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 145
Induction of anti-tumor immune response by bispecific monoclonal antibodies (bimAbs). 144
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 143
HLA class-I-specific NK receptors belong to two distinct molecular families and display inhibitory or activating function. 143
DNAM-1 and PVR regulate monocyte migration through endothelial junctions 142
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 141
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 138
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 137
P49, a putative HLA-G1 specific inhibitory NK receptor belonging to the immunoglobulin Superfamily. 137
null 135
Effect of Melanoma-derived Fibroblasts on NK Cell Phenotype and Functions 135
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing 134
Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells 133
The three-dimensional structure of NK cell receptor NKp44, a triggering partner in natural cytotoxicity 132
Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. 131
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function 131
Physical and functional association of CD45 and CD3-TCR complex on CD1+ human thymocytes. Evidence that the engagement of CD45 molecules can prevent CD1+ thymocytes from apoptosis. 129
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 129
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. 128
Identification of the rat homologue of the human NKp46 triggering receptor 128
Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. 127
Phenotypic, functional and molecular analysis of CD3- LGL expansions indicates a relationship to two different CD3- normal counterparts. 127
Human natural killer cell function and receptors. 126
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin 126
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 126
Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30 126
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 125
Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity. 124
Human natural killer cell activating receptors. 122
Role of NK cells in immunotherapy and virotherapy of solid tumors 122
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. 122
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation 121
Human NK cells and their receptors 118
HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells 118
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 118
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. 118
p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily 117
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 117
Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis 117
Cutaneous T Cell Lymphoma Cells Express a Novel Allelic Form of the p140/Killer Cell Immunoglobulin-Like Receptor 116
Human natural killer cell receptors: insights into their molecular function and structure 116
null 116
Human decidua contains NK cell committed CD34+ hematopoietic precursors able to differentiated into functional Natural Killer cells 115
Human natural killer cell receptors and co-receptors. 114
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 113
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule 113
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production. 113
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity 112
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. 110
The corticosteroid-induced inhibitory effect on NK cell function reflects downregulation and/or disfunction of triggering receptors involved in natural cytotoxicity. 110
Cultured human NK cells express the Ki-1/CD30 antigen. 110
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 110
The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. 108
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 107
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans 107
Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor 105
Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules. 104
Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. 103
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. 101
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. 101
Identification, molecular cloning and functional characterization of NKp46 and NKp30 Natural Cytotoxicity Receptors in Macaca fascicularis (Macaca Rhesus) NK cells 99
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. 98
null 96
Natural killer cells in pregnancy: how they may avoid their attack to fetal tissues 95
Selective cross-talk among natural cytotoxicity receptors in human natural killers cells 95
METODO PER L'ANALISI CINETICA DI PRODUZIONE DI CITOCHINE E/O CHEMOCHINE DA PARTE DI SINGOLI SUBSET DI CELLULE NATURAL KILLER UMANE 95
MELANOMA CELLS INTERFERE WITH THE ACTIVITY OF NK CELLS BY MODULATING THEIR PHENOTYPE AND CYTOTOXIC FUNCTION 94
The innate immune cross talk between NK cells and eosinophils is regulated by the interaction of Natural Cytotoxicity Receptors with eosinophil surface ligands 94
Totale 13.483
Categoria #
all - tutte 47.157
article - articoli 44.605
book - libri 0
conference - conferenze 1.882
curatela - curatele 0
other - altro 0
patent - brevetti 556
selected - selezionate 0
volume - volumi 114
Totale 94.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021573 0 0 0 0 0 95 48 78 83 101 91 77
2021/20221.419 59 111 132 170 60 75 75 334 54 121 68 160
2022/20231.265 126 81 14 145 205 244 0 86 195 4 152 13
2023/2024644 24 76 17 92 75 101 23 41 52 20 43 80
2024/20252.173 37 155 108 149 347 222 192 299 97 98 206 263
2025/20261.609 416 96 231 290 478 98 0 0 0 0 0 0
Totale 15.050